Out-of-pocket costs for cancer survivors between 5 and 10 years from diagnosis: an Italian population-based study

Supportive Care in Cancer

Volumn 24, Issue 5, 2016, Pages 2225-2233

  Baili, Paolo ^a   Di Salvo, Francesca ^a   de Lorenzo, Francesco ^b   Maietta, Francesco ^c   Pinto, Carmine ^d,e   Rizzotto, Vera ^c   Vicentini, Massimo ^f,g   Rossi, Paolo Giorgi ^f,g   Tumino, Rosario ^h   Rollo, Patrizia Concetta ^h   Tagliabue, Giovanna ^a   Contiero, Paolo ^a   Candela, Pina ⁱ   Scuderi, Tiziana ⁱ   Iannelli, Elisabetta ^b   Cascinu, Stefano ^e   Aurora, Fulvio ^j   Agresti, Roberto ^a   Turco, Alberto ^a   Sant, Milena ^a   Meneghini, Elisabetta ^a   Micheli, Andrea ^a   more..

^a NATIONAL CANCER INSTITUTE   (Italy)

^b Federazione italiana delle Associazioni di Volontariato in Oncologia FAVO   (Italy)

^c Centro Studi Investimenti Sociali (CENSIS)   (Italy)

^d UNIVERSITY HOSPITAL OF PARMA   (Italy)

^e Italian Association of Medical Oncology (AIOM)   (Italy)

^f PATHOLOGY UNIT   (Italy)

^g S MARIA NUOVA HOSPITAL   (Italy)

^h Ragusa Cancer Registry   (Italy)

ⁱ Viale della Provincia   (Italy)

^j Association Senza Limiti   (Italy)

more..

Author keywords

Cancer prevalence; Cancer registry; Cancer survivorship; Out of pocket costs

Indexed keywords

ABDOMINAL CANCER; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CANCER REGISTRY; CANCER SURVIVOR; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENERAL PRACTITIONER; HEALTH CARE COST; HEALTH CARE SYSTEM; HUMAN; ITALIAN (CITIZEN); MAJOR CLINICAL STUDY; MALE; ONCOLOGIST; PATIENT TRANSPORT; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; ECONOMICS; EPIDEMIOLOGY; ITALY; MIDDLE AGED; MORTALITY; NEOPLASM; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA; SURVIVOR; TIME FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; HEALTH EXPENDITURES; HUMANS; ITALY; MALE; MIDDLE AGED; NEOPLASMS; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES; SURVIVORS; TIME FACTORS;

EID: 84947092958     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-015-3019-8     Document Type: Article

References (27)

1. Micheli A, Francisci S, Krogh V, Rossi AG, Crosignani P (1999) Cancer prevalence in Italian cancer registry areas: the ITAPREVAL study. ITAPREVAL Working Group. Tumori 85(5):309–369
2. Micheli A, Mugno E, Krogh V, Quinn MJ, Coleman M, Hakulinen T, Gatta G, Berrino F, Capocaccia R, EUROPREVAL Working Group (2002) Cancer prevalence in European registry areas. Ann Oncol 13(6):840–865
3. Micheli A, Yancik R, Krogh V, Verdecchia A, Sant M, Capocaccia R, Berrino F, Ries L (2002) Contrasts in cancer prevalence in Connecticut, Iowa, and Utah. Cancer 95(2):430–439
4. Maddams J, Utley M, Møller H (2011) Levels of acute health service use among cancer survivors in the United Kingdom. Eur J Cancer 47(14):2211–2220. doi:10.1016/j.ejca.2011.04.015
5. Baili P, Hoekstra-Weebers J, Van Hoof E, Bartsch HH, Travado L, Garami M, Di Salvo F, Micheli A, Veerus P, EUROCHIP-3 Working group on Cancer Rehabilitation (2013) Cancer rehabilitation indicators for Europe. Eur J Cancer 49:1356–1364. doi:10.1016/j.ejca.2012.10.028
6. AIRTUM Working Group (2010) Italian cancer figures, report 2010: cancer prevalence in Italy. Patients living with cancer, long-term survivors and cured patients. Epidemiol Prev 34(5–6 Suppl 2):1–188. http://www.registri-tumori.it/cms/?q=Rapp2010. Accessed 16 September 2015
7. Parry C, Kent EE, Mariotto AB, Alfano CM, Rowland JH (2011) Cancer survivors: a booming population. Cancer Epidemiol Biomarkers Prev 20:1996–2005. doi:10.1158/1055-9965.EPI-11-0729
8. Gatta G, Mallone S, van der Zwan JM, Trama A, Siesling S, Capocaccia R, EUROCARE Working Group (2013) Cancer prevalence estimates in Europe at the beginning of 2000. Ann Oncol 24:1660–1666. doi:10.1093/annonc/mdt030
9. Dal Maso L, Guzzinati S, De Angelis R, AIRTUM Working Group (2014) Italian cancer figures, report 2014: prevalence and cure of cancer in Italy. Epidemiol Prev 38(6 Suppl 1):1–122. http://www.registri-tumori.it/cms/it/Rapp2014. Accessed 16 September 2015
10. Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R, EUROCARE Working Group (2009) EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary. Eur J Cancer 45(6):931–991. doi:10.1016/j.ejca.2008.11.018
11. Dal Maso L, Guzzinati S, Buzzoni C, Capocaccia R, Serraino D, Caldarella A, Dei Tos AP, Falcini F, Autelitano M, Masanotti G, Ferretti S, Tisano F, Tirelli U, Crocetti E, De Angelis R, the AIRTUM Working group (2014) Long-term survival, prevalence, and cure of cancer: a population-based estimation for 818,902 Italian patients and 26 cancer types. Ann Oncol 25(11):2251–2260. doi:10.1093/annonc/mdu383
12. De Angelis R, Grande E, Inghelmann R, Francisci S, Micheli A, Baili P, Meneghini E, Capocaccia R, Verdecchia A (2007) Cancer prevalence estimates in Italy from 1970 to 2010. Tumori 93(4):392–397
13. Meropol NJ, Schulman KA (2007) Cost of cancer care: issues and implications. J Clin Oncol 25(2):180–186
14. Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML (2011) Projections of the cost of cancer care in the United States: 2010–2020. J Natl Cancer Inst 103(2):117–128. doi:10.1093/jnci/djq495, Erratum in: J Natl Cancer Inst. 103(8):699
15. Brown ML, Yabroff KR (2006) Economic impact of cancer in the United States. In: Schottenfeld D, Fraumeni JF (eds) Cancer epidemiology and prevention, 3rd edn. Oxford University Press, New York
16. Pisu M, Azuero A, McNees P, Burkhardt J, Benz R, Meneses K (2010) The out of pocket cost of breast cancer survivors: a review. J Cancer Surviv 4(3):202–209. doi:10.1007/s11764-010-0125-y
17. US National Library of Medicine National Institutes of Health. PubMed. http://www.ncbi.nlm.nih.gov/pubmed Accessed 16 September 2015
18. Osservatorio sulla condizione assistenziale dei malati oncologici (2012) 4° Rapporto sulla condizione assistenziale dei malati oncologici. In Italian. http://www.favo.it/download/category/31-quarto-rapporto.html?download=172:quarto-rapporto-integrale. Accessed 16 September 2015
19. Culyer AJ, Newhouse JP (2000) Handbook of health economics, vol 1B. Elsevier Science B.V, Amsterdam
20. Jones AM (2002) Econometric analysis of health data. John Wiley & Sons, Chichester
21. Vuong QH (1989) Likelihood ratio tests for model selection and non-nested hypotheses. Econometrica 57:307–333
22. Guy GP Jr, Ekwueme DU, Yabroff KR, Dowling EC, Li C, Rodriguez JL, de Moor JS, Virgo KS (2013) Economic burden of cancer survivorship among adults in the United States. J Clin Oncol 31(30):3749–3757. doi:10.1200/JCO.2013.49.1241
23. Associazione Italiana dei Registri Tumori. ITACAN database. http://itacan.ispo.toscana.it/italian/itacan.htm. Accessed 16 September 2015
24. Istituto nazionale di statistica (ISTAT). www.istat.it. Accessed 16 September 2015
25. Sant M, Minicozzi P, Allemani C, Cirilli C, Federico M, Capocaccia R, Budroni M, Candela P, Crocetti E, Falcini F, Ferretti S, Fusco M, Giacomin A, La Rosa F, Mangone L, Natali M, Leon MP, Traina A, Tumino R, Zambon P (2012) Regional inequalities in cancer care persist in Italy and can influence survival. Cancer Epidemiol 36:541–547. doi:10.1016/j.canep.2012.06.006
26. Giorgi Rossi P, Beccaro M, Miccinesi G, Borgia P, Costantini M, Chini F, Baiocchi D, De Giacomi G, aria Grimaldi M, Montella M, the ISDOC Working Group (2007) Dying of cancer in Italy: impact on family and caregiver. The Italian Survey of Dying of Cancer. J Epidemiol Community Health 61:547–554. doi:10.1136/jech.2005.045138
27. Italian Ministry of Health. Italy: Technical Policy Document on the reduction of cancer disease burden 2011–2013. www.epaac.eu/from_heidi_wiki/Italy_National_Oncology_Plan_Italian.pdf, www.epaac.eu/from_heidi_wiki/Italy_National_Oncology_Plan_Summary_English.pdf. Accessed 16 September 2015